Multi-year investments in Danish research provide peace of mind

A broad majority in the Danish Parliament has reached an agreement on multi-year billion-dollar investments in Danish research and innovation. The Danish pharma trade group Lif sees the long-term investments as an important step to maintain and expand Denmark's strong position within life science, health and innovation.

Last week, a majority in the Danish Parliament reached an agreement on the so-called research reserve, and with the agreement, public investments in research until 2029 have been determined.

"It is positive that more predictability and a long-term framework for Danish research are now being created. The multi-year investments – including the significant funds for health and life science – are important for Denmark's position as a life science country," says Anders Hoff, political head of research and innovation at Lif.